Skip to main content
    D

    Dr. Reddy’s Laboratories Ltd ADR (RDY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $12.93
    +0.18 (+1.41%)

    Market Cap: $10.64B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(22/34)
    Avg Surprise
    +240.84%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $85.0B
    Range$83.1B - $87.3B
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $89.9B
    Range$88.2B - $93.0B
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-N/A---
    Sep 26EST
    		-N/A---
    Jun 26
    Reported Jul 21
    		$0.06N/A-64.71%Miss-99.6%
    Mar 26
    Reported May 11
    		$0.03N/A-82.18%Miss-99.8%
    Dec 25
    Reported Jan 20
    		$0.16$0.16+1.94%Beat-99.0%
    Sep 25
    Reported Oct 24
    		$0.20N/A-98.92%Miss-98.8%
    Jun 25
    Reported Jul 23
    		$17.02$0.21+8004.76%Beat+1.9%
    Mar 25
    Reported May 9
    		$19.11$17.13+11.56%Beat+23.0%
    Dec 24
    Reported Jan 29
    		$16.94$16.15+4.89%Beat+1.8%
    Sep 24
    Reported Nov 5
    		$15.83$17.69-10.51%Miss-11.1%
    Jun 24
    Reported Jul 27
    		$16.70$17.12-2.45%Miss-0.9%
    Mar 24
    Reported May 8
    		$15.54$13.55+14.69%Beat+29.5%
    Dec 23
    Reported Jan 31
    		$16.64$13.26+25.49%Beat+12.1%
    Sep 23
    Reported Oct 27
    		$17.81$11.60+53.53%Beat+31.9%
    Jun 23
    Reported Jul 26
    		$16.85$10.51+60.32%Beat+17.6%
    Mar 23
    Reported May 10
    		$12.00$10.90+10.09%Beat+17042.9%
    Dec 22
    Reported Jan 25
    		$14.84$9.55+55.39%Beat+73.6%
    Sep 22
    Reported Oct 28
    		$13.50$9.39+43.77%Beat+12.5%
    Jun 22
    Reported Jul 28
    		$14.33$8.37+71.21%Beat+109.2%
    Mar 22
    Reported May 23
    		$0.07N/A-87.27%Miss-84.8%
    Dec 21
    Reported Jan 28
    		$8.55$12.84-33.41%Miss+1055.4%
    Sep 21
    Reported Oct 29
    		$12.00$9.54+25.79%Beat+30.4%
    Jun 21
    Reported Jul 27
    		$6.85$9.82-30.24%Miss-0.6%
    Mar 21
    Reported May 14
    		$0.46$0.51-9.80%Miss-24.6%
    Dec 20
    Reported Jan 29
    		$0.74N/A-90.41%Miss-91.8%
    Sep 20
    Reported Oct 28
    		$9.20$7.19+27.96%Beat-29.9%
    Jun 20
    Reported Jul 29
    		$6.89$7.85-12.23%Miss-13.7%
    Mar 20
    Reported May 20
    		$0.61$0.49+24.49%Beat+63.8%
    Dec 19
    Reported Jan 27
    		$9.05$7.20+25.69%Beat+2123.0%
    Sep 19
    Reported Nov 1
    		$13.12$7.01+87.16%Beat+3076.0%
    Jun 19
    Reported Jul 29
    		$7.98$5.14+55.25%Beat+1896.5%
    Mar 19
    Reported May 17
    		$0.37$0.33+12.88%Beat+39.5%
    Dec 18
    Reported Feb 1
    		$0.41$0.32+27.22%Beat-98.4%
    Sep 18
    Reported Oct 26
    		$0.41$0.30+37.70%Beat-97.6%
    Jun 18
    Reported Jul 26
    		$0.40$0.27+48.04%Beat-88.8%
    Mar 18
    Reported May 22
    		$0.27$0.33-19.06%Miss-98.6%
    Dec 17
    Reported Jan 25
    		$25.73N/AN/ABeat+5988.5%
    Sep 17
    Reported Oct 31
    		$17.15N/AN/ABeat-
    Jun 17
    Reported Jul 27
    		$3.56N/AN/ABeat-
    Mar 17
    Reported Jun 19
    		$18.75N/AN/ABeat-
    Dec 16
    Reported Feb 4
    		$0.42N/AN/ABeat-

    Dividends

    Dividend Metrics

    Forward Yield0.50%
    Forward Annual Dividend$0.06
    Payout Ratio27.20%
    FrequencyAnnual
    Pay MonthsJul, Aug

    Growth

    3Y CAGR+5.74%
    5Y CAGR+6.53%
    RDY dividend history and ex-dividend datesRun RDY in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio28.81EV/EBITDA16.90x
    Price/FCF64.35xFCF Yield1.55%
    Profitability
    Profit Margin10.00%Operating Margin4.25%
    ROE8.84%ROIC7.29%
    Financial Health
    Debt/Equity0.19xInterest Coverage9.71x
    Current Ratio1.90xQuick Ratio1.39x
    Trading Statistics
    Beta0.25Avg Volume3.15M
    52-Week High$15.5152-Week Low$11.28

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$12.53
    SMA 20$12.48
    SMA 50$12.25
    SMA 200$13.15
    EMA 10$12.62
    EMA 20$12.48
    EMA 50$12.41
    EMA 200$12.98

    MACD

    Line: 0.15Signal: 0.10Hist: 0.05

    ADX

    ADX: 16.2+DI: 35.4-DI: 24.0

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down12.0
    PSAR$12.05

    Bollinger Bands

    Upper Band$12.96
    Lower Band$12.00
    %B Position764%(Upper)
    Band Width0.97

    RSI (14-Day)

    Neutral
    62.2

    Momentum Oscillators

    Stoch %K81.2
    Stoch %D76.7
    Williams %R-10.5
    ROC (10d)5.6%
    Momentum0.68
    CCI (20d)145.3
    MFI (14d)54.1

    Volatility Measures

    ATR (14d)$0.29(2.2%)
    StdDev (20d)0.24
    Hist Vol25.7%(Moderate)

    Volume Flow

    VWAP$12.94
    OBV25.0M
    AD Line-680.1M
    CMF (20d)-0.079

    Volume Metrics

    Avg Vol (20d)3.1M
    Vol Ratio0.8x
    VWMA (20d)$12.49

    Pivot Points

    R3$13.20
    R2$13.07
    R1$12.91
    Pivot Point$12.78
    S1$12.62
    S2$12.49
    S3$12.33

    Advanced Oscillators

    TSI13.34
    Ultimate Osc53.9
    KST35.06

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$81.18B$76.33B$87.27B$88.05B$85.45B$85.06B$83.59B$80.16B$76.73B$70.83B$72.15B$832.20M
    Cost of Revenue$43.42B$42.12B$40.46B$39.91B$36.83B$37.80B$34.53B$32.39B$30.38B$29.35B$29.95B$363.25M
    Gross Profit$37.76B$34.22B$46.81B$48.14B$48.63B$47.26B$49.05B$47.77B$46.34B$41.48B$42.20B$468.95M
    Operating Expenses$34.79B$33.74B$32.57B$30.63B$31.15B$29.62B$30.33B$30.22B$28.42B$26.52B$25.30B$293.22M
    R&D$5.80B$5.55B$6.15B$6.20B$6.24B$7.26B$6.66B$7.27B$6.19B$6.88B$5.57B$65.88M
    SG&A$26.10B$14.47B$15.88B$26.44B$23.18B$24.05B$24.12B$23.01B$22.69B$20.48B$20.23B$28.86B
    Operating Income$2.97B$473.25M$14.24B$17.51B$17.48B$17.65B$18.72B$17.55B$17.93B$14.96B$17.27B$175.72M
    Interest Income$999.00M$0$921.00M$912.00M$828.00M$564.00M$704.00M$665.00M$744.00M$647.00M$583.00M$311.00M
    Interest Expense$1.26B$1.07B$951.84M$907.00M$830.00M$656.00M$818.00M$757.00M$598.00M$593.00M$394.00M$353.00M
    Income Before Tax$5.56B$2.02B$15.43B$18.35B$19.05B$20.05B$18.74B$19.17B$18.82B$16.02B$18.26B$231.44M
    Income Tax Expense$1.18B$-217,329,000$3.53B$4.08B$4.95B$4.18B$4.70B$5.75B$4.90B$2.95B$4.47B$52.42M
    Net Income$4.46B$2.24B$12.10B$14.37B$14.18B$15.94B$14.13B$12.55B$13.92B$13.07B$13.79B$179.01M
    EBITDA$8.34B$8.76B$19.72B$24.31B$24.64B$25.26B$24.28B$23.90B$21.76B$20.32B$21.29B$4.02B
    EBIT$2.97B$3.10B$14.51B$19.26B$19.88B$20.71B$19.56B$19.92B$17.95B$16.61B$17.52B$235.20M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RDY

    News

    Dr Reddy's Laboratories stock in focus as USFDA completes pre-approval inspection at FTO-9 plant

    Dr. Reddy's Laboratories shares will be in focus after the USFDA completed a pre-approval inspection at its FTO-9 facility...

    Business Today•10/14/26•Somewhat-Bearish

    An FDA pre-approval inspection ends with observations at Dr. Reddy’s (RDY) Visakhapatnam plant.

    Dr. Reddy’s Laboratories Limited announced that a Pre-Approval Inspection (PAI) conducted by the USFDA at its FTO-9 manufacturing facility in Visakhapatnam, Andhra Pradesh...

    Stock Titan•10/14/26•Somewhat-Bearish

    Dr. Reddy's Laboratories advances Tuesday, underperforms market

    Dr. Reddy's Laboratories Ltd. shares increased by 0.74% on Tuesday, closing at 1,239.65 Indian rupees, despite the broader market's strong performance with the BSE SENSEX Index rising 1.54%. The company's stock is...

    MarketWatch•10/13/26•Neutral

    Dr. Reddy’s ADR tests ₹12.99 resistance, bull trap risk: Live

    Dr. Reddy’s Labs ADR is currently testing a significant resistance level at ₹12.99. While bullish indicators suggest potential for a breakout...

    Investing.com India•10/12/26•Somewhat-Bearish

    Dr Reddy's Gets 2 USFDA Form 483 Observations at Andhra Pradesh Facility

    The USFDA issued two observations via Form 483 to Dr Reddy's Laboratories' FTO-11 manufacturing facility in Pydibhimavaram, Andhra Pradesh, following a Pre-Approval Inspection from October 5 to October 7...

    Medical Dialogues•10/9/26•Somewhat-Bearish

    RDY Valuation and Fair Value

    P/E
    28.8x
    Forward P/E
    27.0x
    EV/EBITDA
    16.9x
    P/FCF
    64.4x
    PEG
    1.6x
    P/B
    2.7x
    See GNG's fair value

    RDY Profitability: Margins, ROIC and FCF

    Gross margin
    50.3%
    Operating margin
    4.3%
    Net margin
    10.0%
    ROIC
    7.3%
    ROE
    8.8%
    FCF margin
    416.5%
    FCF yield
    1.6%

    RDY Competitors

    CompanyTicker
    Molina Healthcare IncMOH
    Oscar Health IncOSCR
    Universal Health Services IncUHS
    Immunitybio IncIBRX
    Vaxcyte IncPCVX
    Madrigal Pharmaceuticals IncMDGL
    Fresenius Medical Care CorporationFMS
    Align Technology IncALGN

    Sector: Healthcare

    RDY Analyst Ratings

    Consensus
    Hold
    Analysts
    5
    Strong Buy
    0
    Buy
    2
    Hold
    2
    Sell
    1
    Strong Sell
    0

    RDY Bull Case vs Bear Case

    Bull case

    • RDY converts 416.5% of revenue into free cash flow.

    Bear case

    • RDY's quarterly revenue changed -5.6% year over year.

    RDY Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    970.9%

    RDY Dividend

    Forward yield
    0.5%
    Payout ratio
    27.2%
    3Y DPS growth
    5.7%
    5Y DPS growth
    6.5%
    Pay months
    Jul, Aug
    RDY dividend history

    Frequently Asked Questions About RDY

    What is RDY's current dividend yield?

    Dr. Reddy’s Laboratories Ltd ADR (RDY) has a forward dividend yield of 0.50%.

    Does RDY pay dividends?

    Yes, Dr. Reddy’s Laboratories Ltd ADR pays dividends with a forward dividend yield of 0.50%.

    What is RDY's P/E ratio?

    Dr. Reddy’s Laboratories Ltd ADR has a price-to-earnings (P/E) ratio of 28.81.

    What is RDY's market cap?

    Dr. Reddy’s Laboratories Ltd ADR (RDY) has a market capitalization of $10.64B with a current stock price of $12.93.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In